Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIMMDC1 (Complex I assembly factor TIMMDC1, mitochondrial) is a multi-pass transmembrane protein of the inner mitochondrial membrane and an essential chaperone for assembly and stabilization of respiratory chain complex I (NADH:ubiquinone oxidoreductase)[1][2][4]. It is structurally related to the TIM17-TIM22-TIM23 family, containing four predicted transmembrane domains and localizing both its N- and C-termini to the mitochondrial matrix[1][4]. TIMMDC1 enables stepwise assembly of both the membrane and soluble arms of complex I by interacting with the MCIA assembly complex, core subunits, and additional complex I assembly factors[1][2]. Loss of TIMMDC1 impairs complex I assembly, disrupts mitochondrial respiration, and is associated with neurodegenerative disease, severe neurologic dysfunction, and inherited complex I deficiency syndromes[1][3][4]. Overexpression of TIMMDC1 has been linked to increased metastatic behavior in lung carcinoma cells, while depletion impairs cell growth, migration, and regulation of apoptosis[4]. There are currently no approved drugs directly targeting TIMMDC1.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complex I assembly factor TIMMDC1, mitochondrial (TIMMDC1).